PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
15-Jul-2020 Sosei Heptares notes Enerzair® Breezhaler® approval in the European Union as a treatment for uncontrolled asthma Sosei Group Corporation
15-Jul-2020 ARRAYJET SECURES $1MILLION BIO PRINTER CONTRACT WITH WORLD’S LARGEST PROTEIN MICROARRAY PRODUCER Arrayjet
15-Jul-2020 ISPE Announces Formation of New Eurasian Economic Union Affiliate ISPE
15-Jul-2020 Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 for the Treatment of Angelman Syndrome in Europe Ovid Therapeutics
15-Jul-2020 Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate Medicago
15-Jul-2020 XBiotech Announces Discovery that Blocking Interleukin-1a Reduces Brain Injury and Neurological Deficit After Stroke XBiotech Inc
15-Jul-2020 Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia Invivoscribe, Inc
15-Jul-2020 Byondis Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine in Advanced Endometrial Cancer Byondis B.V.
15-Jul-2020 Bridge Biotherapeutics becomes BaseLaunch’s first Asia Pacific partner BaseLaunch
15-Jul-2020 J&J's price reduction of lifesaving TB drug is an important step; governments must scale up use Johnson & Johnson
15-Jul-2020 Half of British public ‘scared’ of going to hospital due to COVID-19 risk and time-wasting Incisive Health
13-Jul-2020 Elucid Digital Health’s dashboard gives pharma and CROs real time patient adherence data during a clinical trial Elucid Digital Health
08-Jul-2020 PTC Therapeutics Announces First Patient Dosed in Phase 1 Trial for PTC857 PTC Therapeutics, Inc
08-Jul-2020 PureTech Founded Entity Sonde Health Launches New Voice-Enabled Health Screening Tool to Potentially Help Employers Return to Work During the Global Pandemic PureTech Health plc
08-Jul-2020 EMA Validates and Grants Accelerated Assessment for Trastuzumab Deruxtecan for the Treatment of HER2 Positive Metastatic Breast Cancer AstraZeneca
08-Jul-2020 National strategy for digital scientific discovery urgently required to tackle global crises The Royal Society of Chemistry
08-Jul-2020 Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer AstraZeneca PLC
07-Jul-2020 Byondis’ Investigational Antibody-Drug Conjugate SYD985 Selected for I-SPY 2 TRIAL™ in Early-Stage Breast Cancer Byondis
06-Jul-2020 Greensill provides much needed cash to England’s Pharmacies Greensill
06-Jul-2020 Rentschler Biopharma and Vetter Team Up with Joint Goal to Simplify Processes and Optimize Time-To-Market Rentschler Biopharma